课程介绍
大家好，我是Annika Smith博士，是澳大利亚悉尼的皮肤科顾问医师。今天我很荣幸向大家介绍在EADV大会展示上的3项研究壁报。这些壁报聚焦于一项随机对照试验结果，旨在改善银屑病患者心血管疾病预防效果。
众所周知，银屑病是一种系统性的炎症性疾病，它的影响不止于皮肤表面。银屑病患者的心血管代谢疾病风险更高，而针对这一群体的心血管疾病预防往往被忽视。我们的工作目标是将皮肤病学和心脏病学结合起来，以填补这一空白。 第1张壁报探讨了研究的主要结果。我们的随机试验测试了一个简单的短信提醒程序，该项目旨在支持成年银屑病患者的心血管疾病预防。在6个月时，干预组患者的能动性更高，对地中海饮食的依从性更好，参加的体育活动更多，BMI和血压也有所改善。重要的是，提升患者对银屑病和心血管疾病之间关联的认知，患者的药物依从性也会有所改善。 第2张壁报关注的是患者对该程序的反馈。我们发现这个程序受到了参与者的广泛好评。90%的参与者认为发短信既实用又起到激励作用。许多人报告称他们的生活方式得到了显著改善。 第3张壁报探讨了该队列的基线心血管代谢特征。尽管传统的心血管风险因素发生率较高（包括高血压、糖尿病和血脂异常），但预防性药物的使用率却低得惊人。抑郁和焦虑也很普遍，这确实凸显了在皮肤科诊疗中存在尚未满足的需求，将结构化心血管代谢筛查和预防纳入皮肤科诊疗体系中。
总体而言，这3张壁报展示了3个关键内容：首先，银屑病患者有较高的心脏代谢负担，我们必须明白这是一种系统性炎症性疾病；一个简单且低成本的短信提醒可以改善患者的生活方式和自我管理情况，重要的是，对于患者来说这很有吸引力且增强自身能力；最后，这些结果确实指向了一个切实的机会，将心血管疾病预防和教育纳入常规皮肤病诊疗中，将心血管健康置于银屑病的核心位置。
My name's Dr. Annika Smith, consultant dermatologist based in Sydney, Australia. Today I've got the great pleasure of presenting to you three posters presented here at EADV. That centered on the outcomes of a randomized control trial designed to improve cardiovascular prevention in psoriasis.
So we know that psoriasis is a systemic inflammatory disease. It's more than skin deep, and it carries a heightened risk of cardiometabolic disease and cardiovascular prevention in this cohort is often overlooked. Our work serves to bring together dermatology and cardiology in order to address this gap. So our 1st poster looked at the main trial outcomes. Our randomized trial tested a simple text messaging program designed to support cardiovascular prevention in the psoriasis cohort in adults with psoriasis. At six months, the intervention group had higher patient activation, better Mediterranean diet adherence, more physical activity, and modest improvements in BMI and blood pressure. Importantly, knowledge of the psoriasis cardiovascular disease link improved, as did medication adherence. Our 2nd poster focused on patient feedback with respect to this program. And overwhelmingly, We found this program was well received by participants. 90% of participants found the text messaging useful and motivating. Many reported significant lifestyle improvements. Our 3rd poster looked at baseline cardiometabolic profiling in this cohort, and despite high rates of traditional cardiovascular risk factors, including hypertension, diabetes and dyslipidemia, preventative medication use was surprisingly low. Depression and anxiety were also prevalent, and really this underscores the unmet need for structured Cardiometabolic screening and prevention embedded in dermatology care.
So in closing, all three posters show three key things. Firstly, psoriasis patients carry a high cardiometabolic burden, and we really must understand this condition as a systemic inflammatory disease. A simple low-cost text messaging program can improve lifestyle and self-management, and patients importantly found this engaging and empowering. Finally, these findings really point towards a real opportunity to embed cardiovascular prevention and education into routine dermatology care, serving to place the heart at the center of psoriasis care.
